Upadhyaya M, Han S, Consoli C, Majounie E, Horan M, Thomas NS, et al
Food and Drug Administration (FDA) has warned against the use of GLP-1 RA by individuals with personal or family history of medullary thyroid cancer and hereditary conditions associated with this type of cancer. With this in mind, investigators evaluated whether people with type 2 diabetes who take GLP-1 RAs are at a higher risk of developing thyroid cancer compared with those taking other common diabetes medications
The process of losing weight can be emotionally complex, involving: Anxiety about treatment success or failure Heightened body awareness and preoccupation with physical changes Stress related to dietary modifications and lifestyle adjustments Excitement or anticipation about weight loss progress These emotional states can manifest as difficulty falling asleep or maintaining sleep, independent of any pharmacological effect
However, emerging evidence suggests that GIP resistance can be modified and restored by improving glycaemic control
Additionally, it has been observed that maternal weight loss with metformin does not have a significant impact on newborn birth weight (Feig et al., 2023)
K., Tchkonia, T
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
